title: The effects of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma.
abstract: It was found that gepirone and 1-(2-pyrimidinyl)-piperazine (1-PP) increased levels of corticosterone in plasma in the intact rat. Gepirone was more potent and more efficacious than its metabolite, 1-PP. The ED50 was 6.4 mumol/kg for gepirone and 65.4 mumol/kg for 1-PP. Forty-five min after intraperitoneal administration, gepirone and 1-PP produced maximum increases in corticosterone of 283% and 211%, respectively, above control values. The amplitude and duration of the effects of the drugs were dependent on the ongoing activity in the hypothalamic-pituitary-adrenal axis. Consequently, the greatest absolute increases in corticosterone were produced during the afternoon when the activity in the hypothalamic-pituitary-adrenal axis was greatest. A single 10 mg/kg dose of gepirone significantly elevated levels of corticosterone in plasma (313% after 1 hr) above control values for 2 hr during afternoon trials and for 1 hr (244%) during morning trials. In addition, it was found that the effects of the administration of gepirone and of stress on the levels of corticosterone in plasma were additive. In the light of other work on the hypothalamic-pituitary-adrenal axis, these results suggest that the increased levels of corticosterone, elicited by gepirone, were mediated through a serotonergic action rather than through noradrenergic activity.
authors.affiliation: Neurobiology Laboratory, Indiana University School of Medicine, Evansville 47722.
authors.forename: G K
authors.initials: GK
authors.lastname: Matheson
authors.forename: D
authors.initials: D
authors.lastname: Gage-White
authors.forename: G
authors.initials: G
authors.lastname: White
authors.forename: D
authors.initials: D
authors.lastname: Guthrie
authors.forename: J
authors.initials: J
authors.lastname: Rhoades
authors.forename: V
authors.initials: V
authors.lastname: Dixon
mesh_terms: D000818:Animals; D002065:Buspirone / Q000031:analogs & derivatives* / Q000494:pharmacology; D002940:Circadian Rhythm; D003345:Corticosterone / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008297:Male; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013312:Stress, Physiological / Q000503:physiopathology
chemical_list: D011743:Pyrimidines; C037921:1-(2-pyrimidinyl)piperazine; C039979:gepirone; D002065:Buspirone; D003345:Corticosterone